| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.17 | 6e-06 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-05 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.25 | 1e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.26 | 2e-05 |